Tenet Healthcare Corp header image

Tenet Healthcare Corp

THC

Equity

ISIN US88033G4073 / Valor 19722583

New York Stock Exchange, Inc (2024-09-18)
USD 161.07+2.62%

Tenet Healthcare Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Tenet Healthcare Corp is a multinational healthcare services company that operates hospitals and other healthcare facilities.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (06.08.2024):

Net Income

Tenet Healthcare Corp's net income available to common shareholders for the second quarter of 2024 was $259 million, or $2.64 per diluted share. This represents a significant increase from the $123 million, or $1.15 per diluted share, reported in the second quarter of 2023.

Adjusted EBITDA

For the second quarter of 2024, Tenet Healthcare Corp reported an Adjusted EBITDA of $945 million, reflecting a 12.1% increase over the $843 million reported in the second quarter of 2023. This growth was driven by strong same-hospital admission growth and favorable payer mix.

Ambulatory Care Segment

Tenet Healthcare Corp's Ambulatory Care segment reported an Adjusted EBITDA of $447 million for the second quarter of 2024, a 20.8% increase compared to the $370 million reported in the second quarter of 2023. This growth was attributed to strong net revenue per case growth and acquisitions of new facilities.

Share Repurchase Program

In the second quarter of 2024, Tenet Healthcare Corp's Board of Directors authorized a new $1.5 billion share repurchase program. This decision follows the completion of the company's previous $1 billion share repurchase program.

2024 Financial Outlook

Tenet Healthcare Corp has raised its financial outlook for the full year 2024. The company now expects its Adjusted EBITDA to be in the range of $3.825 billion to $3.975 billion, a $300 million increase from previous estimates. Additionally, the Free Cash Flow outlook has been increased to a range of $1.100 billion to $1.350 billion.

Summarized from source with an LLMView Source

Key figures

130%1Y
121%3Y
544%5Y

Performance

36.6%1Y
47.3%3Y
60.5%5Y

Volatility

Market cap

16021 M

Market cap (USD)

Daily traded volume (Shares)

202,444

Daily traded volume (Shares)

1 day high/low

162.59 / 156.73

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.30%EUR 27.34
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%EUR 9.59
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.27%EUR 37.42
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.24%EUR 8.38
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%CHF 268.40
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.71%CHF 81.58
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203211
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%CHF 286.80
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.47%CHF 125.85
Galderma Group Ltd
Galderma Group Ltd Galderma Group Ltd Valor: 133539272
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.77%CHF 79.42
Sandoz Group Ltd
Sandoz Group Ltd Sandoz Group Ltd Valor: 124359842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.87%CHF 34.78